Forte Biosciences (FBRX) Total Debt (2016 - 2019)

Forte Biosciences (FBRX) has 4 years of Total Debt data on file, last reported at $22.1 million in Q2 2019.

• Total Debt for Q2 2019 came in at $22.1 million, down 14.8% year-over-year; the trailing twelve-month figure through Jun 2019 was $22.1 million (down 14.8% YoY), and the FY2018 annual result was $26.2 million, up 622.79% from the prior year.
• Total Debt slipped to $22.1 million in Q2 2019 per FBRX's latest filing, from $24.1 million in the prior quarter.
• Over five years, Total Debt peaked at $26.2 million in Q4 2018 and troughed at $2.0 million in Q1 2018.
• A 4-year average of $14.6 million and a median of $10.2 million in 2016 frame the typical range for Total Debt.
• The sharpest annual moves came in 2018 and 2019: Total Debt slumped 77.02% in 2018, then surged 1124.09% in 2019.
• A 4-year view of Total Debt shows it stood at $10.2 million in 2016, then plunged by 64.6% to $3.6 million in 2017, then soared by 622.79% to $26.2 million in 2018, then declined by 15.73% to $22.1 million in 2019.
• Business Quant data shows FBRX's Total Debt at $22.1 million in Q2 2019, $24.1 million in Q1 2019, and $26.2 million in Q4 2018.